IRIDEX (IRIX) Competitors $1.15 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.16 +0.01 (+0.87%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRIX vs. ICCM, QTI, LUNG, MDAI, TELA, SURG, CTSO, DXR, PYPD, and SRTSShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include IceCure Medical (ICCM), QT Imaging (QTI), Pulmonx (LUNG), Spectral AI (MDAI), TELA Bio (TELA), SurgePays (SURG), Cytosorbents (CTSO), Daxor (DXR), PolyPid (PYPD), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. IRIDEX vs. Its Competitors IceCure Medical QT Imaging Pulmonx Spectral AI TELA Bio SurgePays Cytosorbents Daxor PolyPid Sensus Healthcare IceCure Medical (NASDAQ:ICCM) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings. Is ICCM or IRIX more profitable? IRIDEX has a net margin of -10.95% compared to IceCure Medical's net margin of -317.62%. IceCure Medical's return on equity of -136.96% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets IceCure Medical-317.62% -136.96% -71.46% IRIDEX -10.95%-386.93%-17.42% Which has preferable earnings and valuation, ICCM or IRIX? IRIDEX has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIceCure Medical$3.29M21.30-$15.32M-$0.16-6.38IRIDEX$48.67M0.40-$8.91M-$0.33-3.48 Does the media prefer ICCM or IRIX? In the previous week, IceCure Medical had 1 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for IceCure Medical and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 1.91 beat IceCure Medical's score of 0.85 indicating that IRIDEX is being referred to more favorably in the news media. Company Overall Sentiment IceCure Medical Positive IRIDEX Very Positive Which has more volatility and risk, ICCM or IRIX? IceCure Medical has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Do institutionals and insiders have more ownership in ICCM or IRIX? 0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 7.4% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate ICCM or IRIX? IceCure Medical currently has a consensus price target of $2.39, suggesting a potential upside of 133.82%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe IceCure Medical is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00IRIDEX 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryIRIDEX beats IceCure Medical on 9 of the 17 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXLASERS IndustryComputer SectorNASDAQ ExchangeMarket Cap$19.54M$1.04B$32.03B$10.42BDividend YieldN/AN/A3.19%4.69%P/E Ratio-3.48N/A450.5326.35Price / Sales0.4065.691,925.32124.96Price / CashN/A27.5234.9330.68Price / Book8.855.407.256.39Net Income-$8.91M-$60.02M$815.14M$276.69M7 Day PerformanceN/A-2.85%-0.70%-0.30%1 Month Performance-14.18%-4.92%7.11%6.68%1 Year Performance-35.75%10.36%24,243.96%27.58% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX0.8327 of 5 stars$1.15flatN/A-35.8%$19.54M$48.67M-3.48120ICCMIceCure Medical2.1941 of 5 stars$1.07+1.9%$2.39+122.9%+63.3%$72.13M$3.29M-6.6960QTIQT ImagingN/A$2.58-2.5%N/A+240.6%$70.09M$4.00M0.00N/APositive NewsLUNGPulmonx3.3655 of 5 stars$1.84+8.9%$7.66+316.5%-79.0%$68.86M$83.79M-1.29250MDAISpectral AI2.8177 of 5 stars$2.35-2.5%$3.50+48.9%+73.6%$64.42M$29.58M-3.4183High Trading VolumeTELATELA Bio2.8275 of 5 stars$1.61-0.6%$4.50+179.5%-44.9%$64.18M$69.30M-1.44120SURGSurgePays3.1913 of 5 stars$2.97+1.0%$9.00+203.0%+56.6%$60.07M$60.88M-1.1940CTSOCytosorbents2.0765 of 5 stars$0.97+2.6%$5.50+469.4%-37.8%$59.06M$35.60M-5.68220Gap DownHigh Trading VolumeDXRDaxor3.8529 of 5 stars$11.76-1.0%$25.00+112.6%+35.5%$57.46MN/A0.0037Gap UpPYPDPolyPid3.259 of 5 stars$3.55+2.9%$12.40+249.3%-7.7%$54.85MN/A-0.9380Analyst UpgradeSRTSSensus Healthcare2.6038 of 5 stars$3.15+1.3%$8.00+154.0%-47.3%$51.13M$41.81M-52.5040Positive NewsGap Down Related Companies and Tools Related Companies ICCM Alternatives QTI Alternatives LUNG Alternatives MDAI Alternatives TELA Alternatives SURG Alternatives CTSO Alternatives DXR Alternatives PYPD Alternatives SRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRIX) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
